What Is Alhemo, and Why Does It Matter? Alhemo (concizumab-mtci) is a medicine approved to help prevent bleeding in people aged 12 or older with hemophilia A or B who don’t have inhibitors to certain ...

Hemophilia is a rare genetic condition that prevents your blood from clotting and can lead to bleeding problems. People with hemophilia can have bleeding episodes that happen without trauma and can ...

There is no cure for hemophilia, but treatments like factor replacement therapy and medications such as Hemgenix help by replacing missing clotting factors or promoting clot formation. Lifestyle ...

Once-weekly prophylaxis with efanesoctocog alfa (Altuviiio) led to high sustained factor VIII activity and was effective in preventing bleeding among children with severe hemophilia A, the phase III ...

In a recent study, a research team led by Professor Hyun Hye-kyung and Professor Heo Cheol-woong of Yonsei University's Yongin Severance Hospital (Hospital Director Kim Eun-kyung), Professor Kim ...

Doctors are reporting an increase in the number of parents refusing Vitamin K shots for their newborns. They say it's putting ...